;
Skip to main content
Home > The Daily Extra > Financial News

Chronological Index of : Financial News

 Current Issue
  • FINANCIAL NEWS: Newco Flex raises $40 million in venture round

    Flex Pharma Inc. (Boston, Mass.) raised $40 million in an undisclosed venture round to develop treatments for neuromuscular disorders. Investors include Longwood Fund; Bessemer Venture Partners; EcoR1 Capital; Jennison …

    Published on 9/8/2014
  • FINANCIAL NEWS: PRA Health files for $375 million IPO

    CRO PRA Health Sciences Inc. (Raleigh, N.C.) filed to raise up to $375 million in an IPO on NASDAQ underwritten by Jefferies; Citigroup; KKR; UBS Investment Bank; Credit Suisse; Wells Fargo Securities; Baird; and …

    Published on 9/8/2014
  • FINANCIAL NEWS: ProQR sets IPO range

    ProQR Therapeutics B.V. (Leiden, the Netherlands) set terms for its IPO on NASDAQ. The company plans to sell 6.3 million shares at $11-$13. At the $12 midpoint, the company would raise $75 million and be valued at $251.…

    Published on 9/8/2014
  • FINANCIAL NEWS: Ribomic sets IPO range

    Ribomic Inc. (Tokyo, Japan) plans to sell 1.2 million shares at Y2,000-Y2,300 in its IPO on the Tokyo Stock Exchange's Mothers. At the Y2,150 midpoint Ribomic would raise Y2.6 billion ($24.5 million) and be valued at …

    Published on 9/8/2014
  • FINANCIAL NEWS: Vitae sets IPO terms

    Vitae Pharmaceuticals Inc. (Fort Washington, Pa.) set the terms for its IPO on NASDAQ. The company plans to sell 5 million shares at $11-$13. At the $12 midpoint, Vitae would raise $60 million and be valued at $186 …

    Published on 9/8/2014
  • FINANCIAL NEWS: Clovis prices $250M note deal

    Clovis Oncology Inc. (NASDAQ:CLVS) raised $250 million through the sale of convertible senior notes to institutional investors. The notes bear 2.5% interest and mature on September 15, 2021. The notes initially convert …

    Published on 9/4/2014
  • FINANCIAL NEWS: Depomed raises $300M in bumped-up note deal

    Depomed Inc. (NASDAQ:DEPO) raised $300 million through the sale of convertible senior notes. The notes bear 2.5% interest and mature on Sept. 1, 2021. The notes initially convert at $19.24, a 26% premium to the company'…

    Published on 9/4/2014
  • FINANCIAL NEWS: Fractyl raises $40M in series C

    Diabetes company Fractyl Laboratories Inc. (Waltham, Mass.) raised $40 million in a series C round led by new investor Mithril. Existing investors General Catalyst; Bessemer Venture Partners; and Domain Associates also …

    Published on 9/4/2014
  • FINANCIAL NEWS: Propeller raises $14.5 million in B round

    Propeller Health (Madison, Wis.) raised $14.5 million in a series B round led by new investor Safeguard Scientifics Inc. (NYSE:SFE). Existing investor The Social+Capital Partnership also participated along with …

    Published on 9/4/2014
  • FINANCIAL NEWS: rEVO sets IPO terms

    rEVO Biologics Inc., a subsidiary of LFB S.A. (Les Ulis, France), set the terms for its IPO on NASDAQ. It plans to sell 3.6 million shares at $13-$15. LFB plans to purchase $10 million of the IPO shares and invest $10 …

    Published on 9/4/2014
  • FINANCIAL NEWS: Foamix sets IPO range

    Israeli dermatology play Foamix Pharmaceuticals Ltd. (Ness Ziona, Israel) amended its IPO on NASDAQ and now plans to sell 5.9 million shares at $10-$12. At the $11 midpoint, the company would raise $65 million and be …

    Published on 9/3/2014
  • FINANCIAL NEWS: Affimed sets IPO terms, raises series E

    Cancer immunotherapy company Affimed Therapeutics AG (Heidelberg, Germany) set the terms for a planned IPO on NASDAQ and also said it closed a EUR 11.7 million ($15.4 million) series E round. The company plans to sell 6…

    Published on 9/2/2014
  • FINANCIAL NEWS: Chiesi, Pappas launch rare disease-focused VC firm

    Chiesi Farmaceutici S.p.A. (Parma, Italy) and A. M. Pappas & Associates launched a new VC firm, Chiesi Ventures, to invest in early stage research on rare and orphan diseases. A. M. Pappas is an investor but said Chiesi…

    Published on 9/2/2014
  • FINANCIAL NEWS: Clearside raises $16 million B round

    Ophthalmic play Clearside Biomedical Inc. (Alpharetta, Ga.) raised $16 million in a series B round led by new investor RusnanoMedInvest. Existing investors Hatteras Venture Partners; Santen Pharmaceuticals Co. Ltd. (…

    Published on 9/2/2014
  • FINANCIAL NEWS: Clovis planning $200 million note deal

    Clovis Oncology Inc. (NASDAQ:CLVS) proposed late Tuesday to raise $200 million through the sale of senior convertible notes due 2021 in a private placement to institutional investors. Clovis' rucaparib (CO-338) is in …

    Published on 9/2/2014
  • FINANCIAL NEWS: Sofinnova Partners hires Richter as partner

    Sofinnova Partners hired Henrijette Richter as a partner. She was an investment director of Novo Seeds at Novo A/S. Sofinnova Partners has over EUR 1.3 billion ($1.7 billion) under management.

    Published on 9/2/2014
  • FINANCIAL NEWS: Tokai and Viking set IPO terms

    Tokai Pharmaceuticals Inc. (Cambridge, Mass.) and Viking Therapeutics Inc. (San Diego, Calif.) both set terms for planned IPOs on NASDAQ. Tokai plans to sell of 5.4 million shares at $13-$15. At $14, the company would …

    Published on 9/2/2014
  • FINANCIAL NEWS: Orexo raises $50.6 million

    Orexo AB (SSE:ORX; OTCQX:ORXOY) raised SEK346.5 million ($50.6 million) through the sale of 2.5 million shares at SEK139 in a private placement. The company sold 1.1 million treasury shares and issued 1.4 million new …

    Published on 8/29/2014
  • FINANCIAL NEWS: Titan proposes to raise up to $12 million

    Titan Pharmaceuticals Inc. (OTCBB:TTNP) proposed to raise up to $12 million through the sale of units in a follow-on underwritten by Roth Capital Partners. Each unit comprises a share and a warrant to purchase a share.…

    Published on 8/29/2014
  • FINANCIAL NEWS: Orexo raising private placement

    Orexo AB (SSE:ORX; OTCQX:ORXOY) is raising an undisclosed amount in a private placement with Swedish and international institutional and strategic investors. Danske Bank is the sole lead manager and bookrunner.Orexo …

    Published on 8/28/2014
  • FINANCIAL NEWS: Bellicum secures $55 million in series C

    Bellicum Pharmaceuticals Inc. (Houston, Texas) secured $55 million in a series C round from 11 new investors, including RA Capital; Perceptive Advisors; Jennison Associates; Sabby Capital; Ridgeback Capital Management; …

    Published on 8/27/2014
  • FINANCIAL NEWS: Capnia amends IPO

    Capnia Inc. (Redwood City, Calif.) amended its IPO on NASDAQ and now plans to raise $11.1 million through the sale of 1.7 million units at $6.50. Each unit comprises a share and a five-year warrant to purchase a share …

    Published on 8/27/2014
  • FINANCIAL NEWS: Dermatology play Dermira files for IPO

    Dermira Inc. (Redwood City, Calif.) filed to raise up to $75 million in an IPO on NASDAQ underwritten by Citigroup; Leerink; Guggenheim Securities; and Needham. Dermira said partner UCB Group (Euronext:UCB) may purchase…

    Published on 8/27/2014
  • FINANCIAL NEWS: Napo's Jaguar Animal Health files for IPO

    The Jaguar Animal Health Inc. subsidiary of Napo Pharmaceuticals Inc. (San Francisco, Calif.) filed to raise up to $70 million in an IPO on NASDAQ underwritten by BMO Capital Markets; Guggenheim Securities; and Roth …

    Published on 8/27/2014
  • FINANCIAL NEWS: Rhythm files for IPO

    Rhythm Pharmaceuticals Inc. (Boston, Mass.) filed to raise up to $86.3 million in an IPO on NASDAQ underwritten by Citigroup; Cowen; Canaccord Genuity; Oppenheimer; and Cantor Fitzgerald. Rhythm expects to begin a Phase…

    Published on 8/27/2014

< Previous   1  2  3  4  5  6  Next >
Subscribe Now
Free Trial

About BioCentury

Decision-shaping business intelligence for the global biotech and pharma industry since 1993